Published in Transplant Proc on August 01, 1990
RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection. Ann Surg (1992) 1.11
Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial. Br J Ophthalmol (1999) 1.08
[Systemic immunosuppressives after penetrating keratoplasty]. Ophthalmologe (2007) 0.99
Effect of mycophenolate mofetil, cyclosporin A, and both in combination in a murine corneal graft rejection model. Br J Ophthalmol (1998) 0.98
Pharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosus. Semin Arthritis Rheum (2010) 0.98
Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis. Recent Pat Biomed Eng (2012) 0.82
Experience with mycophenolate mofetil (RS61443) in renal transplantation at a single center. Ann Surg (1993) 0.78
Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes. Antimicrob Agents Chemother (1994) 0.78
Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches. Cell Mol Immunol (2016) 0.77
Effects of mycophenolate mofetil on proliferation and mucin-5AC expression in human conjunctival goblet cells in vitro. Mol Vis (2010) 0.77
Mycophenolic acid formulations in adult renal transplantation - update on efficacy and tolerability. Ther Clin Risk Manag (2009) 0.76
The changing face of liver transplantation. Gut (1993) 0.75
Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation. J Ophthalmic Vis Res (2017) 0.75
An examination of the cytotoxic effects of silica on macrophages. J Exp Med (1966) 8.42
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature (2001) 7.35
gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science (2001) 4.90
Role of contractile microfilaments in macrophage movement and endocytosis. Nat New Biol (1971) 4.82
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J Exp Med (1989) 4.66
Macrophages and age-dependent resistance to Herpes simplex virus in mice. J Immunol (1970) 4.15
Membrane fusion. Biochim Biophys Acta (1973) 3.75
Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice. J Immunol (1970) 3.49
Mycophenolate mofetil and its mechanisms of action. Immunopharmacology (2000) 3.41
Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci U S A (1988) 3.34
M-antiglobulins (rheumatoid-factor-like globulins) and other gamma-globulins in relation to tropical parasitic infections. Lancet (1966) 3.31
Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation. Nature (1971) 3.30
Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem (2000) 3.12
Identification of human mononuclear leucocyte populations by esterase staining. Clin Exp Immunol (1977) 3.12
Protection of mice against Babesia and Plasmodium with BCG. Nature (1976) 3.01
Asbestos induces selective release of lysosomal enzymes from mononuclear phagocytes. Nature (1974) 2.86
Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J Exp Med (1977) 2.84
Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment. Lancet (1978) 2.80
Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance. J Exp Med (1974) 2.72
Effects of antilymphocyte serum on virus oncogenesis. Proc Soc Exp Biol Med (1968) 2.63
Effects of activated complement components on enzyme secretion by macrophages. Immunology (1976) 2.63
Babesia microti and Plasmodium berghei yoelii infections in nude mice. Nature (1974) 2.55
Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med (1974) 2.54
An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J Immunol Methods (1986) 2.50
Potentiation by silica of the growth of Mycobacterium tuberculosis in macrophage cultures. Br J Exp Pathol (1968) 2.48
Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med (2001) 2.47
Interactions of antibodies, complement components and various cell types in immunity against viruses and pyogenic bacteria. Transplant Rev (1974) 2.45
Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. J Immunol (1976) 2.34
Physico-chemical properties of silica in relation to its toxicity. Nature (1966) 2.32
Lymphocytes binding human thyroglobulin in healthy people and its relevance to tolerance for autoantigens. Lancet (1973) 2.28
Protection of mice against Babesia spp. and Plasmodium spp. with killed Corynebacterium parvum. Parasitology (1977) 2.28
Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes. J Exp Med (1974) 2.25
Mechanisms by which activated macrophages inhibit lymphocyte responses. Immunol Rev (1978) 2.24
Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans. Infect Immun (1976) 2.16
Heterophile antibodies, M-antiglobulins and immunoglobulins in experimental trypanosomiasis. Clin Exp Immunol (1969) 2.16
The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest (1990) 2.08
A role of macrophages in the stimulation of immune responses by adjuvants. J Immunol (1969) 2.06
Role of contractile microfilaments in the release of histamine from mast cells. Nature (1972) 1.99
Role of lysosomes and of cell membranes in photosensitization. Nature (1966) 1.91
Use of cyclosporin A in allogeneic bone marrow transplantation in the rat. Nature (1979) 1.90
The inhibition of phagocytosis and facilitation of exocytosis in rabbit polymorphonuclear leukocytes by cytochalasin B. Lab Invest (1973) 1.89
The role of cell-mediated immune responses in resistance to malaria, with special reference to oxidant stress. Annu Rev Immunol (1983) 1.88
Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis. Lancet (1971) 1.88
Ability of activated complement components to induce lysosomal enzyme release from macrophages. Nature (1976) 1.85
Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology. Biochemistry (Mosc) (2005) 1.85
Mineral fibers: chemical, physicochemical, and biological properties. Adv Pharmacol Chemother (1975) 1.83
Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol (1992) 1.82
Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum (1977) 1.82
Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation. Immunology (1977) 1.82
Tissue thromboplastin activity of isolated human monocytes. Thromb Haemost (1978) 1.81
Mode of action of adjuvants: effects on antibody responses to macrophage-associated bovine serum albumin. J Immunol (1970) 1.79
Immune responses in mice with murine leprosy. Clin Exp Immunol (1970) 1.79
Genetic factors in resistance against virus infections. Arch Gesamte Virusforsch (1965) 1.74
Role of macrophages and antibody in resistance of mice against yellow fever virus. J Immunol (1971) 1.71
The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice. J Med Microbiol (1972) 1.69
Mechanisms of endocytosis and exocytosis. Symp Soc Exp Biol (1974) 1.69
Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cells. Eur J Cancer Clin Oncol (1989) 1.68
The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus. J Gen Virol (1973) 1.68
Role of T lymphocytes in recovery from murine cytomegalovirus infection. Infect Immun (1977) 1.68
Unresponsiveness to self antigens. Lancet (1971) 1.67
Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol (1991) 1.67
Immune complexes induce selective release of lysosomal hydrolases from macrophages. Nature (1974) 1.64
The role of microfilaments and microtubules in cell movement, endocytosis and exocytosis. Ciba Found Symp (1973) 1.61
Monoclonal antibodies to human recombinant interleukin 1 (IL 1)beta: quantitation of IL 1 beta and inhibition of biological activity. J Immunol (1987) 1.61
Control of electron flux through the respiratory chain in mitochondria and cells. Biol Rev Camb Philos Soc (1987) 1.60
Pathogenesis of the chronic inflammatory lesion induced by group A streptococcal cell walls. Lab Invest (1974) 1.60
Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum. Infect Immun (1983) 1.60
Immunity and immunopathology in virus infections. Ann Inst Pasteur (Paris) (1972) 1.60
Participation of mononuclear phagocytes in chronic inflammatory diseases. J Reticuloendothel Soc (1974) 1.59
Selective targeting of an antioxidant to mitochondria. Eur J Biochem (1999) 1.58
RS-61443--a new, potent immunosuppressive agent. Transplantation (1991) 1.57
On the role of mononuclear phagocytes in immunity against viruses. Prog Med Virol (1974) 1.55
Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet (1978) 1.52
Quantitation and origin of the mitochondrial membrane potential in human cells lacking mitochondrial DNA. Eur J Biochem (1999) 1.51
Differences in susceptibility of various mouse strains to haemoprotozoan infections: possible correlation with natural killer activity. Parasite Immunol (1980) 1.48
Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J Immunol Methods (1989) 1.48
Observations on thymectomy and carcinogenesis. Cancer Res (1967) 1.48
Correlation of persistent mouse hepatitis virus (MHV-3) infection with its effect on mouse macrophage cultures. Arch Virol (1976) 1.48
Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects. Clin Exp Immunol (1978) 1.46
Immune complexes in mice infected neonatally with Moloney leukaemogenic and murine sarcoma viruses. Nature (1969) 1.46
A radical interpretation of immunity to malaria parasites. Lancet (1982) 1.46
Absence of a newly described cytochrome b from neutrophils of patients with chronic granulomatous disease. Lancet (1978) 1.45
Chromosome damage in human diploid cells following activation of lysosomal enzymes. Nature (1965) 1.45
Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis. Eur J Clin Invest (1998) 1.44
Specific and non-specific immunity to haemoprotozoa. Am J Trop Med Hyg (1977) 1.43
Cell-mediated immune responses to virus infections and virus-induced tumours. Br Med Bull (1967) 1.43
The possible role of lysosomes in carcinogenesis. Proc R Soc Med (1966) 1.43
Neonatally induced allograft tolerance may be mediated by serum-borne factors. Nature (1971) 1.43
Lysosomes and the toxicity of particulate pollutants. Arch Intern Med (1971) 1.42
Role of adenosine deaminase in lymphocyte proliferation. Clin Exp Immunol (1976) 1.41
Cell-free assays for gamma-secretase activity. FASEB J (2000) 1.41
Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant (1996) 1.41
Induction of specific tolerance in rabbits by kidney allografting and short periods of cyclosporin-A treatment. Lancet (1979) 1.39